Opinions Differ on How Merged Bayer-Monsanto Affects Some Seed Businesses

By Yanchun (Roxanne) Liu Medill Reports Academics and independent seed companies have divergent outlooks on whether the merger between agrichemical giants Monsanto Co. and Bayer AG will drive away potential customers from companies that sell organic seeds and seeds that aren’t non-genetically modified. German drug maker Bayer said in a press release on June 7 […]

People may not inherit parents’ money DNA, experts say

By Roxanne (Yanchun) Liu Medill Reports Lori Schwartz’s father, a 74-year-old doctor, only goes to restaurants for dinner where he can use coupons. Raised in a poor family, her father watches how much he spends all the time despite the good paychecks he now earns, embarrassing his daughter. “I hate it,” she said. “His cheapness […]

Tesla’s share price gets a bump from Model 3 production but the run may not continue

By Roxanne (Yanchun) Liu Medill Reports Shares of luxury electric-car manufacturer Tesla Inc. (TSLA) jumped the week after the company reported scaled-up production of its Model 3 sedan in the first quarter, but concerns about product quality and heightened competition have led to Wall Street’s skepticism about Tesla’s long-term stock price. The Palo Alto, California-based […]

Consumer price rise slows, stirring renewed Fed action speculation

By Roxanne (Yanchun) Liu Medill Reports Consumer Price Index growth slowed to 0.2 percent in February from 0.5 percent in the prior month, the U.S. Bureau of Labor Statistics reported, stirring divergent anticipations of the likely timing of the Federal Reserve’s next move to curb inflation. The February bump was in line with the Wall […]

Abbott buys rights to a vascular balloon, possibly confronting Medtronic

Roxanne (Yanchun) Liu Medill Reports Illinois-based healthcare giant Abbott Laboratories (NYSE: ABT) announced Tuesday that it would pay up to $92 million to secure global commercialization rights for SurVeil, a Minnesota company’s drug-coated vascular balloon designed to treat peripheral artery disease, or PAD, a niche market already occupied by muscular competitors including Medtronic PLC (NYSE: MDT). […]

Baxter tops Wall Street expectations, but sees share price drop

By Yanchun (Roxanne) Liu Medill Reports Baxter International Inc. (NYSE: BAX), Deerfield-based medical product manufacturer, reported adjusted earnings that surpassed Wall Street expectations and declaraed an intention to continue share buybacks. Nevertheless, Baxter shares dropped 2.9 percent Thursday. On a GAAP basis, the company lost $71 million, or 13 cents per diluted share, in the […]

AbbVie share hit 5-year high with strong sales growth in fourth quarter

By Yanchun (Roxanne) Liu Medill Reports Stock of AbbVie Inc. (NYSE: ABBV) soared 13.8 percent, hitting a five-year high, after the North Chicago-based biopharmaceutical company reported Friday quarterly adjusted earnings that beat Wall Street expectations and strong growth in sales of flagship drug Humira. However, net earnings plunged 96.3 percent to $52 million, or 3 […]

Johnson & Johnson Q4 Report: huge loss to tax provision but strong sales growth

By Yanchun (Roxanne) Liu Johnson & Johnson (NYSE: JNJ), one of the world’s largest pharmaceutical makers, reported Tuesday a huge net loss occasioned by a tax charge on cash outside the United States, along with a healthy increase in adjusted quarterly earnings that slightly beat Wall Street expectations. The stock dropped 4.3 percent. The New […]